Prescription drug · ANDA
Clonidine NDC 75907-023
Clonidine .1 mg/24h · Patch, Extended release · Transdermal · Dr. Reddy's Labratories Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 75907-023-48 | 75907002348 | 4 POUCH in 1 CARTON (75907-023-48) / 1 PATCH in 1 POUCH (75907-023-11) / 24 h in 1 PATCHMarketed from Feb 10, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Clonidine
- Generic name (nonproprietary)
- clonidine
- Active ingredients
- Clonidine — .1 mg/24h
- Dosage form
- Patch, Extended release
- Route
- Transdermal
- Labeler
- Dr. Reddy's Labratories Inc.
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 079090
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic alpha2-Agonists (Mechanism)
- Identifiers
- Product ID 75907-023_07b162a5-9473-c1d7-9cba-aef238255deeSPL ID 07b162a5-9473-c1d7-9cba-aef238255deeSPL set ID a179570b-eef1-176a-820c-5f603d222a60RxCUI 998671, 998675, 998679UNII MN3L5RMN02
- Pharmacologic class
- Central alpha-2 Adrenergic Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Transdermal products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N475907002348followed by a unit qualifier and the quantityPackage 75907-0023-48. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Clonidine transdermal system is indicated in the treatment of hypertension. It may be employed alone or concomitantly with other antihypertensive agents.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 079090
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Clonidine | Clonidine .3 mg/24h | Patch, Extended releaseTransdermal | Dr. Reddy's Labratories Inc. | 75907-025 |
| Clonidine | Clonidine .2 mg/24h | Patch, Extended releaseTransdermal | Dr. Reddy's Labratories Inc. | 75907-024 |
| Clonidine | Clonidine .3 mg/24h | Patch, Extended releaseTransdermal | Mayne Pharma Inc. | 51862-455 |